(a)
(b)
Figure 3: (a) Overall survival after resection according to recurrent CA19-9 levels in intrahepatic cholangiocarcinoma patients with normalized postoperative CA19-9 levels (). (b) Recurrence-free survival according to recurrence CA19-9 levels in intrahepatic cholangiocarcinoma patients with normalized postoperative CA19-9 levels ().